CN108997327A - The preparation method of aztreonam ethyl ester - Google Patents

The preparation method of aztreonam ethyl ester Download PDF

Info

Publication number
CN108997327A
CN108997327A CN201810764301.XA CN201810764301A CN108997327A CN 108997327 A CN108997327 A CN 108997327A CN 201810764301 A CN201810764301 A CN 201810764301A CN 108997327 A CN108997327 A CN 108997327A
Authority
CN
China
Prior art keywords
aztreonam
preparation
ethyl ester
added
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810764301.XA
Other languages
Chinese (zh)
Inventor
何兆海
洪荣川
袁明华
张闯
陈伟东
万军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fu'an Pharmaceutical Group Pharmaceutical Co Ltd Chongqing Bosheng
Original Assignee
Fu'an Pharmaceutical Group Pharmaceutical Co Ltd Chongqing Bosheng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fu'an Pharmaceutical Group Pharmaceutical Co Ltd Chongqing Bosheng filed Critical Fu'an Pharmaceutical Group Pharmaceutical Co Ltd Chongqing Bosheng
Priority to CN201810764301.XA priority Critical patent/CN108997327A/en
Publication of CN108997327A publication Critical patent/CN108997327A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention belongs to pharmaceutical technology fields, and in particular to a kind of preparation method of aztreonam ethyl ester.Aztreonam triethylamine (TEA) is added to dissolve in ethyl alcohol and clarify, add acylating agent and catalyst and reacting by the preparation method the following steps are included: using aztreonam as raw material;After completion of the reaction, the reactant aqueous solution of glacial acetic acid is added in aztreonam, 0~-5 DEG C of filterings is cooled to after reaction, filtrate is added ethanol solution hydrochloride and obtains aztreonam ethyl ester through crystallization, growing the grain.It is raw material that the preparation method of aztreonam ethyl ester provided by the invention, which has used technical maturity, purity is high, the aztreonam being easy to get, avoid the complicated technology that impurity is synthesized since side chain, the disadvantages of avoiding HPLC preparation the inefficient of chromatography, low yield, aztreonam ethyl ester is prepared using simple process, purity is high, yield are big, at low cost, suitable for mass industrialized production.

Description

The preparation method of aztreonam ethyl ester
Technical field
The invention belongs to pharmaceutical technology fields, and in particular to a kind of preparation method of aztreonam ethyl ester.
Background technique
Aztreonam (Aztreonarn) is a kind of novel ss-lactam antibiotics of monoamides ring class.Suitable for urinary tract sense The abdominal cavity infections such as dye, lower respiratory tract infection, bloodstream infection, skin soft-tissue infection, peritonitis and reproductive tract infection.Aztreonam Have the characteristics that weak renal toxicity, immunogenicity and penicillins, cephalosporins cross allergy are few, therefore can be used for substituting ammonia Base glycoside drug treats the aerobic Gram-negative bacteria infections of kidney function damage patient;And it can be used in close observation To the patient of penicillin, cephalosporin allergy.In the synthesis process of aztreonam, some by-products can be generated, wherein aztreonam Ethyl ester is exactly one such.In order to preferably control the quality of product, guarantee the drug safety of aztreonam, needs to ammonia song The impurity in south does method validation, therefore, it is necessary to do in-depth study to the synthesis technology of aztreonam impurity.
The preparation for the aztreonam ethyl ester mentioned in document at present is to be concentrated from aztreonam mother liquor, then purified by HPLC It arrives, the method is time-consuming and laborious, and yield is lower;There are also use tert-butyl acetoacetate, 2- isobutyl ethyl bromide, thiocarbamide and two thio Benzothiazole etc. is starting material, preferential to synthesize ethyl ester side chain, then is condensed to yield aztreonam ethyl ester with main ring.Specific synthesis road Line sees below reaction equation:
The synthesis technology is complicated, needs six-step process that aztreonam ethyl ester could be made, and intermediate reaction controlling factor is more, Influence the yield and purity of aztreonam ethyl ester.
Therefore a kind of method for developing simple process and big, the at low cost preparation aztreonam ethyl ester of purity is high, yield.
Summary of the invention
In view of this, the purpose of the present invention is to provide a kind of preparation method of aztreonam ethyl ester, preparation side of the invention It is raw material that method, which has used technical maturity, purity is high, the aztreonam being easy to get, and preparation process is simple, at low cost.
To achieve the above object, the technical solution of the present invention is as follows:
The preparation method of aztreonam ethyl ester, comprising the following steps:
1) using aztreonam as raw material, aztreonam triethylamine (TEA) is added to dissolve in ethyl alcohol and is clarified, acylating agent is added It is reacting with catalyst;
2) aztreonam after completion of the reaction, is added the reactant aqueous solution of glacial acetic acid, 0~-5 DEG C is cooled to after reaction in step 1) Filtering, filtrate are added ethanol solution hydrochloride and obtain aztreonam ethyl ester through crystallization, growing the grain.
Further, the acylating agent be include dicyclohexylcarbodiimide (DCC), N, N- diisopropylcarbodiimide (DIC), one kind of acetic anhydride, chloroacetic chloride.
As a preference, the acylating agent is N, N- diisopropylcarbodiimide.
DIC is liquid, is easy to use, the N of generation, N'- diisopropyl urea dissolves in most of organic solvents, it is easy to logical Solvent extraction removing is crossed, therefore DIC is also commonly used in solid-state synthesis.
As a preference, the acylating agent is dicyclohexylcarbodiimide.
DCC is bi-functional cross-linking agent, chemical formula C13H22N2, it is a kind of reactions such as esterification, amidation commonly dehydrating agent, It can also be used for the synthesis of acid anhydrides, aldehyde, ketone, isocyanates.
Further, the catalyst be include 4-dimethylaminopyridine (DMAP), it is 4- pyrollidinopyridine (4-PPY), right One kind of toluenesulfonic acid.
As a preference, the catalyst is 4-dimethylaminopyridine.DMAP is a kind of acylation of superpower nucleophilic Catalyst.DMAP is to be widely used in chemically synthesized efficient catalyst in recent years, the dimethylamino of supplied for electronic in structure With the resonance of female ring (pyridine ring), can the nitrogen-atoms on strong activation ring carry out nucleophilic displacement of fluorine, be catalyzed high steric-hindrance amino significantly, it is low anti- The acylation (phosphorylated, sulfonylation, phosphinylidyne) of the alkohol and amine of answering property is reacted, and activity is about the 10 of pyridine4~106Times.Use 4- Dimethylamino naphthyridine not only has the advantages that reaction condition is mild, dosage is few, moreover it is possible to improve high steric-hindrance amino, low work as catalyst The speed and yield of the alcohol of property, phenol acylation reaction.
As a preference, the catalyst is 4- pyrollidinopyridine.When bad with DMAP catalytic effect, it can be used 4-PPY, catalytic capability ratio DMAP high.
As a preference, acylating agent is N in the present invention, N- diisopropylcarbodiimide, catalyst is 4- pyrrolidinyl Pyridine.
As a preference, acylating agent is dicyclohexylcarbodiimide in the present invention, catalyst is 4-dimethylaminopyridine.
The following are reaction routes:
It is acylating agent that dicyclohexylcarbodiimide is selected in the present invention, and 4-dimethylaminopyridine is catalyst, dicyclohexyl Carbodiimide with activated carboxyl and can play dehydration, 4-dimethylaminopyridine, can the nitrogen-atoms on strong activation ring carry out Nucleophilic displacement of fluorine is catalyzed high steric-hindrance amino, the acylation reaction of the alkohol and amine of hypoergia significantly;During the preparation process, the two is combined energy Reaction rate is improved, and high income, reaction condition are mild, it is easily controllable.
Further, aztreonam and the molar ratio of triethylamine are 1~1.5:1~2.5 in step 1);The matter of aztreonam and ethyl alcohol Amount is than being 1:1.5~2.5.
As a preference, aztreonam and the molar ratio of triethylamine are 1~1.5:1~2 in step 1);Aztreonam and ethyl alcohol Mass ratio be 1:1.5~2.
The clear temperature of dissolution is 25~35 DEG C in step 1);It is preferred that dissolving clear temperature is 25~32 DEG C.
Further, in step 1) acylating agent, catalyst and aztreonam molar ratio be 1~2:0.025~0.035:1~ 1.5。
As a preference, the molar ratio of acylating agent, catalyst and aztreonam is 1.5:0.03~0.035:1 in step 1) ~1.5.
As a preference, the time reacted in step 1) is 38~50h.It is preferred that the time reacted is 48h.
Further, the mass percent of glacial acetic acid is 12%~17% in the aqueous solution of glacial acetic acid in step 2);Step 2) The molar ratio of aztreonam is 0.3~0.5:1~1.5 in middle glacial acetic acid and step 1).
As a preference, the mass percent of glacial acetic acid is 15%~17% in the aqueous solution of glacial acetic acid in step 2); The molar ratio of glacial acetic acid and aztreonam in step 1) is 0.3~0.5:1~1.15 in step 2).
Further, ethanol solution hydrochloride and the mass ratio of aztreonam in step 1) are 2:4~6 in step 2).
As a preference, ethanol solution hydrochloride and the mass ratio of aztreonam in step 1) are 2:5 in step 2).
As a preference, the reaction time in step 2) is 2~3h.
Further, rear adjusting filtrate pH2.5~3.0 after ethanol solution hydrochloride is added in step 2), keep the temperature 0~-10 DEG C and support Brilliant 48h or more obtains aztreonam ethyl ester in 40~50 DEG C of dry 15h after filtering.
Further, detecting step 1) in aztreonam end of reaction method are as follows: detected with TLC method, mobile phase is second The volume ratio of the mixed solvent of alcohol and methylene chloride, ethyl alcohol and methylene chloride is 1:5.
TLC method monitoring aztreonam of the invention whether fully reacting, testing result is accurate, sensitive, this is for realizing ammonia Quality control, the yield guarantee of bent south ethyl ester are extremely important.
Further, the preparation method further includes step 3): aztreonam ethyl ester obtained is added at room temperature DMSO is dissolved to clarification, adds ethyl alcohol, is cooled to 0~-10 DEG C of growing the grain 48h or more, and the solid was filtered, obtains aztreonam after dry Ethyl ester product.
The beneficial effects of the present invention are: the preparation method of aztreonam ethyl ester provided by the invention used technical maturity, Purity is high, the aztreonam being easy to get are raw material, avoid the complicated technology for synthesizing impurity since side chain, avoid HPLC system Aztreonam ethyl ester is prepared using simple process in the disadvantages of standby the inefficient of chromatography, low yield, and purity is high, yield is big, cost It is low, it is suitable for mass industrialized production.
Specific embodiment
It detailed description of a preferred embodiment of the present invention will be given below.The reality of actual conditions is not specified in preferred embodiment Proved recipe method, usually according to normal condition, illustrated embodiment are but not to be to preferably be illustrated to the contents of the present invention The contents of the present invention are only limitted to illustrated embodiment.So those skilled in the art are according to foregoing invention content to embodiment party Case carries out nonessential modifications and adaptations, still falls within protection scope of the present invention.
Embodiment 1
500g (1.15mol) aztreonam, 156g (1.54mol) TEA are added in 1000g ethyl alcohol, in temperature 25~32 Clarification is dissolved under the conditions of DEG C.It is cooled to 0~5 DEG C after dissolved clarification, DCC310g (1.5mol), DMAP 4g (0.0327mol) is added, delays Slowly it is warming up to room temperature reaction 48h, TLC contact plate (mobile phase ethyl alcohol: methylene chloride=1:5) judges aztreonam end of reaction, is added Glacial acetic acid 27.5g (0.458mol), water 150g react 2.5h, are cooled to 0~-5 DEG C, are filtered to remove by-product, filtrate temperature control 0 ~-5 DEG C, ethanol solution hydrochloride 200g is added, adjusts filtrate pH2.5~3.0, keeps the temperature 0~-10 DEG C of growing the grain 48h or more, filters Aztreonam ethyl ester is obtained in 40~50 DEG C of dry 15h to aztreonam ethyl ester wet-milling.Obtained aztreonam ethyl ester is thick 750g DMSO is added at room temperature and is dissolved to clarification, 5000g ethyl alcohol is added, is cooled to 0~-10 DEG C of growing the grain 48h or more, mistake for product Solid is filtered to obtain, in 40~50 DEG C of dry 15h, obtains 354g aztreonam ethyl ester, yield 70.8%, purity 99.5%.
Embodiment 2
500g (1.15mol) aztreonam, 156g (1.54mol) TEA are added in 1000g ethyl alcohol, in temperature 25~32 Clarification is dissolved under the conditions of DEG C.It is cooled to 0~5 DEG C after dissolved clarification, DIC189.3g (1.5mol), DMAP 4g (0.0327mol) is added, It is to slowly warm up to room temperature reaction 48h, TLC contact plate (mobile phase ethyl alcohol: methylene chloride=1:5) judges aztreonam end of reaction, adds Enter glacial acetic acid 27.5g (0.458mol), water 150g, reacts 2.5h, be cooled to 0~-5 DEG C, be filtered to remove by-product, filtrate temperature control 0~-5 DEG C, ethanol solution hydrochloride 200g is added, adjusts filtrate pH2.5~3.0, keeps the temperature 0~-10 DEG C of growing the grain 48h or more, filtering Aztreonam ethyl ester wet-milling is obtained, in 40~50 DEG C of dry 15h, obtains aztreonam ethyl ester.The aztreonam ethyl ester that will be obtained 750g DMSO is added at room temperature and is dissolved to clarification, 5000g ethyl alcohol is added, is cooled to 0~-10 DEG C of growing the grain 48h or more for crude product, The solid was filtered, in 40~50 DEG C of dry 15h, obtains 342g aztreonam ethyl ester, yield 68.4%, purity 99.4%.
Embodiment 3
500g (1.15mol) aztreonam, 156g (1.54mol) TEA are added in 1000g ethyl alcohol, in temperature 25~32 Clarification is dissolved under the conditions of DEG C.It is cooled to 0~5 DEG C after dissolved clarification, DIC189.3g (1.5mol), 4-PPY 4.45g is added (0.03mol), is to slowly warm up to room temperature reaction 48h, and TLC contact plate (mobile phase ethyl alcohol: methylene chloride=1:5) judges that aztreonam is anti- It should finish, glacial acetic acid 27.5g (0.458mol), water 150g is added, react 2.5h, be cooled to 0~-5 DEG C, be filtered to remove by-product Object 0~-5 DEG C of filtrate temperature control, is added ethanol solution hydrochloride 200g, adjusts filtrate pH2.5~3.0, keeps the temperature 0~-10 DEG C of growing the grains Aztreonam ethyl ester wet-milling is obtained by filtration in 48h or more, in 40~50 DEG C of dry 15h, obtains aztreonam ethyl ester.It will obtain Aztreonam ethyl ester, 750g DMSO is added at room temperature and is dissolved to clarification, addition 5000g ethyl alcohol is cooled to 0~-10 DEG C Growing the grain 48h or more, the solid was filtered, in 40~50 DEG C of dry 15h, obtains 358g aztreonam ethyl ester, yield 71.6%, purity 99.4%.
Embodiment 4
500g (1.15mol) aztreonam, 156g (1.54mol) TEA are added in 1000g ethyl alcohol, in temperature 25~32 Clarification is dissolved under the conditions of DEG C.It is cooled to 0~5 DEG C after dissolved clarification, DCC206.2g (1mol), DMAP 4g (0.0327mol) is added, delays Slowly it is warming up to room temperature reaction 48h, TLC contact plate (mobile phase ethyl alcohol: methylene chloride=1:5) judges aztreonam end of reaction, is added Glacial acetic acid 27.5g (0.458mol), water 150g react 2.5h, are cooled to 0~-5 DEG C, are filtered to remove by-product, filtrate temperature control 0 ~-5 DEG C, ethanol solution hydrochloride 200g is added, adjusts filtrate pH2.5~3.0, keeps the temperature 0~-10 DEG C of growing the grain 48h or more, filters Aztreonam ethyl ester is obtained in 40~50 DEG C of dry 15h to aztreonam ethyl ester wet-milling.Obtained aztreonam ethyl ester is thick 750g DMSO is added at room temperature and is dissolved to clarification, 5000g ethyl alcohol is added, is cooled to 0~-10 DEG C of growing the grain 48h or more, mistake for product Solid is filtered to obtain, in 40~50 DEG C of dry 15h, obtains 306g aztreonam ethyl ester, yield 61.2%, purity 97.6%.
Embodiment 5
500g (1.15mol) aztreonam, 156g (1.54mol) TEA are added in 1000g ethyl alcohol, in temperature 25~32 Clarification is dissolved under the conditions of DEG C.It is cooled to 0~5 DEG C after dissolved clarification, DCC310g (1.5mol), DMAP 2.4g (0.02mol) is added, delays Slowly it is warming up to room temperature reaction 48h, TLC contact plate (mobile phase ethyl alcohol: methylene chloride=1:5) judges aztreonam end of reaction, is added Glacial acetic acid 27.5g (0.458mol), water 150g react 2.5h, are cooled to 0~-5 DEG C, are filtered to remove by-product, filtrate temperature control 0 ~-5 DEG C, ethanol solution hydrochloride 200g is added, adjusts filtrate pH2.5~3.0, keeps the temperature 0~-10 DEG C of growing the grain 48h or more, filters Aztreonam ethyl ester is obtained in 40~50 DEG C of dry 15h to aztreonam ethyl ester wet-milling.Obtained aztreonam ethyl ester is thick 750g DMSO is added at room temperature and is dissolved to clarification, 5000g ethyl alcohol is added, is cooled to 0~-10 DEG C of growing the grain 48h or more, mistake for product Solid is filtered to obtain, in 40~50 DEG C of dry 15h, obtains 298g aztreonam ethyl ester, yield 59.4%, purity 97.2%.
Finally, it is stated that the above examples are only used to illustrate the technical scheme of the present invention and are not limiting, although referring to compared with Good embodiment describes the invention in detail, those skilled in the art should understand that, it can be to skill of the invention Art scheme is modified or replaced equivalently, and without departing from the objective and range of technical solution of the present invention, should all be covered at this In the scope of the claims of invention.

Claims (10)

1. the preparation method of aztreonam ethyl ester, which comprises the following steps:
1) using aztreonam as raw material, aztreonam triethylamine (TEA) is added to dissolve in ethyl alcohol and is clarified, acylating agent is added and urges Agent is reacting;
2) after completion of the reaction, the reactant aqueous solution of glacial acetic acid is added in aztreonam in step 1), and 0~-5 DEG C of mistakes are cooled to after reaction Filter, filtrate are added ethanol solution hydrochloride and obtain aztreonam ethyl ester through crystallization, growing the grain.
2. preparation method according to claim 1, which is characterized in that the acylating agent be include dicyclohexylcarbodiimide (DCC), N, N- diisopropylcarbodiimide (DIC), one kind of acetic anhydride, chloroacetic chloride.
3. preparation method according to claim 1, which is characterized in that the catalyst be include 4-dimethylaminopyridine (DMAP), one kind of 4- pyrollidinopyridine, p-methyl benzenesulfonic acid.
4. preparation method according to claim 1, which is characterized in that in step 1) aztreonam and triethylamine and molar ratio For 1~1.5:1~2.5;The mass ratio of aztreonam and ethyl alcohol is 1:1.5~2.5.
5. preparation method according to claim 1, which is characterized in that acylating agent in step 1), catalyst and aztreonam Molar ratio is 1~2:0.025~0.035:1~1.5.
6. preparation method according to claim 1, which is characterized in that glacial acetic acid in the aqueous solution of glacial acetic acid in step 2) Mass percent is 12%~17%;In step 2) in glacial acetic acid and step 1) molar ratio of aztreonam be 0.3~0.5:1~ 1.5。
7. preparation method according to claim 1, which is characterized in that ethanol solution hydrochloride and ammonia in step 1) in step 2) The mass ratio of Qu Nan is 2:4~6.
8. preparation method according to claim 1, which is characterized in that adjusted after ethanol solution hydrochloride is added after in step 2) Filtrate pH2.5~3.0 keep the temperature 0~-10 DEG C of growing the grain 48h or more in 40~50 DEG C of dry 15h after filtering and it is thick to obtain aztreonam ethyl ester Product.
9. preparation method according to claim 1, which is characterized in that detecting step 1) in aztreonam end of reaction method Are as follows: it is detected with TLC method, mobile phase is the mixed solvent of ethyl alcohol and methylene chloride, and the volume ratio of ethyl alcohol and methylene chloride is 1:5。
10. preparation method according to claim 1, which is characterized in that the preparation method further includes step 3): will be made Aztreonam ethyl ester DMSO be added at room temperature be dissolved to clarification, add ethyl alcohol, be cooled to 0~-10 DEG C of growing the grain 48h with On, the solid was filtered, obtains aztreonam ethyl ester product after dry.
CN201810764301.XA 2018-07-12 2018-07-12 The preparation method of aztreonam ethyl ester Pending CN108997327A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810764301.XA CN108997327A (en) 2018-07-12 2018-07-12 The preparation method of aztreonam ethyl ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810764301.XA CN108997327A (en) 2018-07-12 2018-07-12 The preparation method of aztreonam ethyl ester

Publications (1)

Publication Number Publication Date
CN108997327A true CN108997327A (en) 2018-12-14

Family

ID=64599936

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810764301.XA Pending CN108997327A (en) 2018-07-12 2018-07-12 The preparation method of aztreonam ethyl ester

Country Status (1)

Country Link
CN (1) CN108997327A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102086196A (en) * 2011-01-28 2011-06-08 海南灵康制药有限公司 Novel method for refining aztreonam
CN102584811A (en) * 2011-12-29 2012-07-18 蚌埠丰原涂山制药有限公司 Method for preparing aztreonam
CN103570707A (en) * 2012-07-21 2014-02-12 重庆圣华曦药业股份有限公司 Improved synthetic method of aztreonam
CN103910721A (en) * 2013-01-06 2014-07-09 重庆福安药业(集团)股份有限公司 Aztreonam preparation method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102086196A (en) * 2011-01-28 2011-06-08 海南灵康制药有限公司 Novel method for refining aztreonam
CN102584811A (en) * 2011-12-29 2012-07-18 蚌埠丰原涂山制药有限公司 Method for preparing aztreonam
CN103570707A (en) * 2012-07-21 2014-02-12 重庆圣华曦药业股份有限公司 Improved synthetic method of aztreonam
CN103910721A (en) * 2013-01-06 2014-07-09 重庆福安药业(集团)股份有限公司 Aztreonam preparation method

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JOHN M. JOSEPH: ""Selectivity of Poly(styrene-divinylbenzene) Columns"", 《CHROMATOGRAPHY AND SEPARATION CHEMISTRY》 *
刘琳 等: ""氨曲南杂质的合成"", 《广东化工》 *
刘鹰翔 主编: "《药物合成反应》", 31 August 2017, 中国中医药出版社 *
李丕高 编著: "《现代有机合成化学》", 30 April 2006, 陕西科学技术出版社 *
赵丽华: ""N,N-二异丙基碳二亚胺的合成"", 《山东化工》 *

Similar Documents

Publication Publication Date Title
CN111423452B (en) Intermediate of Rayleigh Lu Geli and preparation method and application thereof
CN101613359B (en) Method for synthesizing cefuroxime sodium
CN103539803B (en) A kind of method preparing ceftriaxone sodium
JPH0249797A (en) Production of erythromycin a oxime and salt thereof
BR112012021406B1 (en) PROCESSES FOR THE SYNTHESIS OF DIARYLTHIOIDANTHOIN COMPOUNDS
CN101007812A (en) Antibacterial drugs cefoxitin preparation process
CN105884628B (en) The preparation method of 2,4- di-t-butyl -5- amino phenols
US20190023681A1 (en) Method and intermediate for preparing tulathromycin
CN111848505B (en) Vardutasteride Process for the preparation of intermediates
CN106220648B (en) A kind of synthesis of tertbutyloxycarbonyl Cefcapene diisopropylamine and purification process
ES2943011T3 (en) Preparation procedure of the deuterated imidazole diketone compound
CN108997327A (en) The preparation method of aztreonam ethyl ester
JPH10511377A (en) Manufacture of cefotaxime
CN109232457A (en) A kind of preparation method of Linezolid
CN103232475B (en) A kind of preparation method of Aspoxicillin trihydrate
JP2008308690A (en) Poly (ethylene glycol) functional derivative and method of producing the same
CN113387882A (en) Preparation method of vatacostat and intermediate thereof
CN103102358A (en) Cephalosporin compound, crystal thereof, and preparation method and application thereof
EA031801B1 (en) Method for preparing an intermediate of iopromide
CN113185538B (en) Preparation method of cefpodoxime acid
CN104230909B (en) A kind of preparation method of Azilsartan
CN110330447A (en) A kind of preparation method and applications of Nafamostat Mesilate intermediate
US6337396B1 (en) Process for preparing crystalline cefadroxil hemihydrate from cefadroxil dimethylformamide solvate
CN108588164A (en) The preparation method of cefozopran hydrochloride
CN104892544A (en) Improved acotiamide intermediate preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20181214

RJ01 Rejection of invention patent application after publication